Journal
PAIN MEDICINE
Volume 18, Issue 12, Pages 2325-2330Publisher
OXFORD UNIV PRESS
DOI: 10.1093/pm/pnx243
Keywords
Chronic Pain; Naloxone; Harm Reduction; Patient Safety; Quality Improvement
Categories
Funding
- Veterans Administration Mental Illness Research, Education and Clinical Center (MIRECC)
- Research in Addiction Medicine Scholars (RAMS) (National Institute on Drug Abuse) [R25DA033211]
- VA Health Services Research and Development
Ask authors/readers for more resources
Objective. Opioid prescribing for chronic pain significantly contributes to opioid overdose deaths in the United States. Naloxone as a take-home antidote to opioid overdose is underutilized and has not been evaluated in the high-risk chronic pain population. The objective was to increase overdose education and naloxone distribution (OEND) to high-risk patients on long-term opioid therapy for pain by utilizing group visits in primary care. Design. Quality improvement intervention among two primary care clinics. Setting. A large, academic facility within the Veterans Health Administration. Subjects. Patients prescribed >= 100 mg morphine-equivalent daily dose or coprescribed opioids and benzodiazepines. Methods. One clinic provided usual care with respect to OEND; another clinic encouraged attendance at an OEND group visit to all of its high-risk patients. Results. We used attendance at group visits, prescriptions of naloxone issued, and patient satisfaction scores to evaluate this format of OEND. Key Results. Group OEND visits resulted in significantly more naloxone prescriptions than usual care. At these group visits, patients were engaged, valued the experience, and all requested a prescription for the naloxone kit. Conclusion. This quality improvement pilot study suggests that OEND group visits are a promising model of care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available